Beaumont Capital

IMU Biosciences operates an online health diagnostic platform aimed at advancing precision medicine through immune system mapping. The platform provides medical consultancy services, offering blood test profiles that assess various health markers, including testosterone, ApoA, ApoB, estradiol, glucose, cholesterol, PSA, and iron. By enabling customers to access insightful and cost-effective health assessments, IMU empowers individuals to take control of their health and well-being.

Melio is a healthtech startup that uses cutting-edge blood test technology to help people maintain an active relationship with their health. The startup provides information about the markers that they include in their analytics, answering all of their clients' questions (what they are, what they are for, how to improve them), and assists them in following up by allowing them to compare results over time. It offers over ten blood test profiles and analyzes over 100 health markers, including testosterone, ApoA, ApoB, estradiol, glucose, cholesterol, PSA, and iron.

DeepCrawl is a comprehensive website crawler that helps businesses assess and enhance their websites' technical health. By providing detailed insights and actionable data, DeepCrawl enables search marketers to improve their websites' visibility and effectively convert organic traffic into revenue. Clients using the platform have reported an average of 62% growth in site visibility within a year. The tool is widely utilized by major global advertising agencies to monitor and address technical issues, ultimately aiming to boost SEO performance and achieve better results for their clients.